Status:

COMPLETED

PrevA Study - Evaluation of an App-based Nutritional Concept

Lead Sponsor:

University of Jena

Conditions:

Reduction of Cardiovascular Risk Factors

Eligibility:

All Genders

20-69 years

Phase:

NA

Brief Summary

The PrevA study is designed to evaluate our developed nutritional concept to implement a heart healthy diet. The nutritional concept based on nutrient-optimized daily menu plans for each study day. Th...

Detailed Description

Smartphone-based communication technologies are developing rapidly, and the number of so-called mobile health applications is rising. The number of validated and scientifically tested offers is compar...

Eligibility Criteria

Inclusion

  • Voluntary participation with documented informed consent
  • Willingness and ability to adhere to the study protocol
  • Males / female) aged ≥ 20 years and ≤ 51 years
  • BMI: ≥ 25 ≤ 35 kg / m2 (obesity grade 1)
  • Owning a smartphone (android)
  • no or moderate alcohol consumption (≤ 2 glasses / week)
  • non-smoker (if possible)

Exclusion

  • Comorbidities:
  • Hypercholesterolemia (genetic defect / familial predisposition)
  • Diabetes mellitus type 1 or 2
  • Thyroid dysfunction (hyper- or hypothyroidism)
  • Food intolerance / allergies to ingredients in the study foods
  • Medications: lipid-lowering drugs, glucocorticoids
  • Dietary supplements: especially n-3 fatty acids, vitamin E.
  • Extremely high physical activity (daily)
  • Alcohol abuse (daily)
  • (smoker) \[if there are not enough test persons available, \> 7 smokers should be included so that a statistical analysis is possible\]
  • Uncontrolled organic diseases
  • Alcohol, drug or drug abuse
  • Participation in other clinical observational studies during or 4 weeks. before starting this study
  • Serious behavioral problems, emotional problems or psychiatric problems which the investigator believes would lead to a lack of compliance
  • Pregnancy, breastfeeding and unsafe contraception
  • Other reasons that are considered important by the investigator

Key Trial Info

Start Date :

April 12 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 12 2021

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04717076

Start Date

April 12 2021

End Date

October 12 2021

Last Update

March 3 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Friedrich-Schiller University

Jena, Thuringia, Germany, 07743